Evidence map›Paper›PMID 26627255›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Murine germinal center B cells require functional Fms-like tyrosine kinase 3 signaling for IgG1 class-switch recombination.

Mattias N D Svensson, Karin M E Andersson, Caroline Wasén, Malin C Erlandsson, Merja Nurkkala-Karlsson, Ing-Marie Jonsson, Mikael Brisslert, Mats Bemark, Maria I Bokarewa

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Evolution and Potential Subfunctionalization of DuplicatedJournal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  6. Flt3 Signaling in B Lymphocyte Development and Humoral Immunity.International journal of molecular sciences · 2022
    Review
  7. Article
  8. Article
  9. Review
  10. Intestinal CD11bFrontiers in immunology · 2021
    Article
  11. Article
  12. The Cytokine Flt3-Ligand in Normal and Malignant Hematopoiesis.International journal of molecular sciences · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Mattias N D SvenssonDepartment of Rheumatology and Inflammation Research at Sahlgrenska Academy, University of Gothenburg, Gothenburg 41346, Sweden; mattias.svensson@rheuma.gu.se.
Karin M E AnderssonDepartment of Rheumatology and Inflammation Research at Sahlgrenska Academy, University of Gothenburg, Gothenburg 41346, Sweden;
Caroline WasénDepartment of Rheumatology and Inflammation Research at Sahlgrenska Academy, University of Gothenburg, Gothenburg 41346, Sweden;
Malin C ErlandssonDepartment of Rheumatology and Inflammation Research at Sahlgrenska Academy, University of Gothenburg, Gothenburg 41346, Sweden;ORCID http://orcid.org/0000-0003-1100-7577
Merja Nurkkala-KarlssonDepartment of Rheumatology and Inflammation Research at Sahlgrenska Academy, University of Gothenburg, Gothenburg 41346, Sweden;
Ing-Marie JonssonDepartment of Rheumatology and Inflammation Research at Sahlgrenska Academy, University of Gothenburg, Gothenburg 41346, Sweden;
Mikael BrisslertDepartment of Rheumatology and Inflammation Research at Sahlgrenska Academy, University of Gothenburg, Gothenburg 41346, Sweden;
Mats BemarkDepartment of Microbiology and Immunology at Sahlgrenska Academy, University of Gothenburg, Gothenburg 41390, Sweden.
Maria I BokarewaDepartment of Rheumatology and Inflammation Research at Sahlgrenska Academy, University of Gothenburg, Gothenburg 41346, Sweden;
University of Gothenburg · SEUniversity Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Switched antibody classes are important for efficient immune responses. Aberrant antibody production to otherwise harmless antigens may result in autoimmunity. The protein kinase fms-like tyrosine kinase 3 receptor (Flt3) has an important role during early B-cell development, but the role of Flt3 in peripheral B cells has not been assessed before. Herein we describe a previously unappreciated role for Flt3 in IgG1 class-switch recombination (CSR) and production. We show that Flt3 is reexpressed on B-cell lymphoma 6(+) germinal center B cells in vivo and following LPS activation of peripheral B cells in vitro. Absence of Flt3 signaling in Flt3 ligand-deficient mice results in impaired IgG1 CSR and accumulation of IgM-secreting plasma cells. On activated B cells, Flt3 is coexpressed and functions in synergy with the common-gamma chain receptor family. B cells from Flt3 ligand-deficient mice have impaired IL-4R signaling, with reduced phosphorylation of signal transducer and activator of transcription (Stat) 6, and demonstrate a failure to initiate CSR to IgG1 with low expression of γ1 germ-line transcripts, resulting in impaired IgG1 production. Thus, functional synergy between Flt3 and IL-4R signaling is critical for Stat-mediated regulation of sterile γ1 germ-line transcripts and CSR to IgG1.

Indexed as

Immunoglobulin Class SwitchingAnimalsApoptosisB-Lymphocytesfms-Like Tyrosine Kinase 3Gene Expression RegulationGerminal CenterImmunoglobulin GImmunoglobulin MLigandsLymphocyte ActivationMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutPlasma CellsFlt3 protein, mousefms-Like Tyrosine Kinase 3Immunoglobulin GImmunoglobulin MLigandsReceptors, Interleukin-4secretory IgMclass-switch recombinationFlt3germinal center B cellsIgG1IL-4R

Identifiers

PMID26627255
PMCPMC4672832
OpenAlexW2177948763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.